Global Osteonecrosis Treatment Market 2019-2023

Global Osteonecrosis Treatment Market 2019-2023

About this market

The introduction of cell therapy to boost the market growth. The development of stem cells is increasing to engineer advanced stem cells-based treatment that can demonstrate better efficacy and has fewer side effects than the available treatments. Technavio’s analysts have predicted that the osteonecrosis treatment market will register a CAGR of more than 6% by 2023.

Market Overview

Rising awareness about osteonecrosis

Osteonecrosis is an idiopathic disease as it occurs without trauma and the early diagnosis increases the chances of treatment. Thus, an increasing awareness among people is expected to propel growth in the global osteonecrosis treatment market.

Availability of alternate therapies

The main aim after getting affected by any disease is to get the condition addressed as soon as possible to avoid the progress of osteonecrosis symptoms. Thus, the available treatment are expected to strongly decelerate the growth of the global osteonecrosis market.

For the detailed list of factors that will drive and challenge the growth of the osteonecrosis treatment market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Mylan and Pfizer the competitive environment is quite intense. Factors such as the rising awareness about osteonecrosis and the expansion of aircraft manufacturing facilities, will provide considerable growth opportunities to osteonecrosis treatment manufactures. Atnahs, Merck Sharp & Dohme, Mylan, Pfizer and Teva Pharmaceutical Industries are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global rare disease drugs market
      • Table Segments of global rare disease drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2028
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • NSAIDs - Market size and forecast 2018-2023
      • Table NSAIDs - Market size and forecast 2018-2023 ($ millions)
      • Table NSAIDs - Year-over-year growth 2019-2023 (%)
    • Other therapeutics - Market size and forecast 2018-2023
      • Table Other therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Other therapeutics - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Introduction of stem cell therapy
    • Strategic alliances
    • Increasing research for the diagnosis of osteonecrosis
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Atnahs
      • Table Atnahs - Vendor overview
      • Table Atnahs - Organizational developments
      • Table Atnahs - Key offerings
      • Table Atnahs - Key customers
    • Merck Sharp & Dohme
      • Table Merck Sharp & Dohme - Vendor overview
      • Table Merck Sharp & Dohme - Business segments
      • Table Merck Sharp & Dohme - Organizational developments
      • Table Merck Sharp & Dohme - Geographic focus
      • Table Merck Sharp & Dohme - Segment focus
      • Table Merck Sharp & Dohme - Key offerings
      • Table Merck Sharp & Dohme - Key customers
    • Mylan
      • Table Mylan - Vendor overview
      • Table Mylan - Business segments
      • Table Mylan - Organizational developments
      • Table Mylan - Geographic focus
      • Table Mylan - Key offerings
      • Table Mylan - Key customers
    • Pfizer
      • Table Pfizer - Vendor overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
      • Table Pfizer - Key customers
    • Teva Pharmaceutical Industries
      • Table Teva Pharmaceutical Industries - Vendor overview
      • Table Teva Pharmaceutical Industries - Business segments
      • Table Teva Pharmaceutical Industries - Organizational developments
      • Table Teva Pharmaceutical Industries - Geographic focus
      • Table Teva Pharmaceutical Industries - Segment focus
      • Table Teva Pharmaceutical Industries - Key offerings
      • Table Teva Pharmaceutical Industries - Key customers
  • Appendix
    • Research methodology gy
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook